Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
pharmaceutical investing Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical investing Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals
Transition Metals Identifies Four New Polymetallic Showings at Pike Warden, Yukon, Including Samples Returning >10,000 ppm Silver and 3.4% Molybdenum
Locksley Appoints Former U.S. Airforce Major General & General Dynamics IT Executive to Advisory Board
